Site specific modification of the human plasma proteome by methylglyoxal.
about
Mass spectrometric determination of early and advanced glycation in biology.MiR-27b augments bone marrow progenitor cell survival via suppressing the mitochondrial apoptotic pathway in Type 2 diabetes.Site-specific analysis of advanced glycation end products in plasma proteins of type 2 diabetes mellitus patients.
P2860
Site specific modification of the human plasma proteome by methylglyoxal.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Site specific modification of the human plasma proteome by methylglyoxal.
@ast
Site specific modification of the human plasma proteome by methylglyoxal.
@en
type
label
Site specific modification of the human plasma proteome by methylglyoxal.
@ast
Site specific modification of the human plasma proteome by methylglyoxal.
@en
prefLabel
Site specific modification of the human plasma proteome by methylglyoxal.
@ast
Site specific modification of the human plasma proteome by methylglyoxal.
@en
P2093
P2860
P1476
Site specific modification of the human plasma proteome by methylglyoxal.
@en
P2093
Craig S Stump
George Tsaprailis
Hussein N Yassine
Michael J Kimzey
Owen R Kinsky
Serrine S Lau
Terrence J Monks
P2860
P304
P356
10.1016/J.TAAP.2015.09.029
P577
2015-10-01T00:00:00Z